Lipigon Pharmaceuticals AB Financial Overview
Lipigon Pharmaceuticals AB's market cap is currently €4.97M. The company's EPS TTM is kr-0.012; its P/E ratio is -0.08; Lipigon Pharmaceuticals AB is scheduled to report earnings on November 20, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
